TY - JOUR
T1 - A resting-state fMRI pattern of spinocerebellar ataxia type 3 and comparison with 18F-FDG PET
AU - van der Horn, Harm J.
AU - Meles, Sanne K.
AU - Kok, Jelmer G.
AU - Vergara, Victor M.
AU - Qi, Shile
AU - Calhoun, Vince D.
AU - Dalenberg, Jelle R.
AU - Siero, Jeroen C.W.
AU - Renken, Remco J.
AU - de Vries, Jeroen J.
AU - Spikman, Jacoba M.
AU - Kremer, Hubertus P.H.
AU - De Jong, Bauke M.
N1 - Funding Information:
J.G.K. received funding from the U4 network.
Publisher Copyright:
© 2022 The Authors
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2022
Y1 - 2022
N2 - Spinocerebellar ataxia type 3 (SCA3) is a rare genetic neurodegenerative disease. The neurobiological basis of SCA3 is still poorly understood, and up until now resting-state fMRI (rs-fMRI) has not been used to study this disease. In the current study we investigated (multi-echo) rs-fMRI data from patients with genetically confirmed SCA3 (n = 17) and matched healthy subjects (n = 16). Using independent component analysis (ICA) and subsequent regression with bootstrap resampling, we identified a pattern of differences between patients and healthy subjects, which we coined the fMRI SCA3 related pattern (fSCA3-RP) comprising cerebellum, anterior striatum and various cortical regions. Individual fSCA3-RP scores were highly correlated with a previously published 18F-FDG PET pattern found in the same sample (rho = 0.78, P = 0.0003). Also, a high correlation was found with the Scale for Assessment and Rating of Ataxia scores (r = 0.63, P = 0.007). No correlations were found with neuropsychological test scores, nor with levels of grey matter atrophy. Compared with the 18F-FDG PET pattern, the fSCA3-RP included a more extensive contribution of the mediofrontal cortex, putatively representing changes in default network activity. This rs-fMRI identification of additional regions is proposed to reflect a consequence of the nature of the BOLD technique, enabling measurement of dynamic network activity, compared to the more static 18F-FDG PET methodology. Altogether, our findings shed new light on the neural substrate of SCA3, and encourage further validation of the fSCA3-RP to assess its potential contribution as imaging biomarker for future research and clinical use.
AB - Spinocerebellar ataxia type 3 (SCA3) is a rare genetic neurodegenerative disease. The neurobiological basis of SCA3 is still poorly understood, and up until now resting-state fMRI (rs-fMRI) has not been used to study this disease. In the current study we investigated (multi-echo) rs-fMRI data from patients with genetically confirmed SCA3 (n = 17) and matched healthy subjects (n = 16). Using independent component analysis (ICA) and subsequent regression with bootstrap resampling, we identified a pattern of differences between patients and healthy subjects, which we coined the fMRI SCA3 related pattern (fSCA3-RP) comprising cerebellum, anterior striatum and various cortical regions. Individual fSCA3-RP scores were highly correlated with a previously published 18F-FDG PET pattern found in the same sample (rho = 0.78, P = 0.0003). Also, a high correlation was found with the Scale for Assessment and Rating of Ataxia scores (r = 0.63, P = 0.007). No correlations were found with neuropsychological test scores, nor with levels of grey matter atrophy. Compared with the 18F-FDG PET pattern, the fSCA3-RP included a more extensive contribution of the mediofrontal cortex, putatively representing changes in default network activity. This rs-fMRI identification of additional regions is proposed to reflect a consequence of the nature of the BOLD technique, enabling measurement of dynamic network activity, compared to the more static 18F-FDG PET methodology. Altogether, our findings shed new light on the neural substrate of SCA3, and encourage further validation of the fSCA3-RP to assess its potential contribution as imaging biomarker for future research and clinical use.
KW - Ataxia
KW - BOLD
KW - Brain glucose metabolism
KW - Disease-related pattern
KW - ICA
KW - Neurodegenerative Diseases
KW - Machado-Joseph Disease/diagnostic imaging
KW - Humans
KW - Fluorodeoxyglucose F18
KW - Magnetic Resonance Imaging/methods
KW - Positron-Emission Tomography/methods
UR - http://www.scopus.com/inward/record.url?scp=85129189730&partnerID=8YFLogxK
U2 - 10.1016/j.nicl.2022.103023
DO - 10.1016/j.nicl.2022.103023
M3 - Article
C2 - 35489193
AN - SCOPUS:85129189730
SN - 2213-1582
VL - 34
SP - 1
EP - 10
JO - NeuroImage: Clinical
JF - NeuroImage: Clinical
M1 - 103023
ER -